Braxia Scientific(DE:4960)
€0.01+0.00 (+20.00%)
DE:4960
Braxia Scientific financials statements
€0.01
At close:+0.00 (+20.00%)
Braxia Scientific (4960) Ratios
0 Followers
Braxia Scientific Ratios
DE:4960's free cash flow for Q2 2024 was C$-168.52K. For the 2024 fiscal year, DE:4960's free cash flow was decreased by C$-1.00 and operating cash flow was C$-168.52K. See a summary of the company’s cash flow.
| Ratios | Jun 23 | Jun 22 | Jun 21 | Mar 20 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 1.00 | 3.81 | 4.47 | 19.57 |
| Quick Ratio | 1.00 | 3.81 | 4.47 | 18.94 |
| Cash Ratio | 0.68 | 3.42 | 4.35 | 16.06 |
| Solvency Ratio | -5.52 | -4.53 | -34.15 | -3.20 |
| Operating Cash Flow Ratio | -3.44 | -1.78 | -1.98 | -5.42 |
| Short-Term Operating Cash Flow Coverage | -148.08 | -90.43 | -101.19 | -5.78 |
| Net Current Asset Value | C$ -123.75K | C$ 6.99M | C$ 8.80M | C$ 989.28K |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.05 | 0.02 | 0.01 | 0.04 |
| Debt-to-Equity Ratio | 0.13 | 0.02 | 0.01 | 0.05 |
| Debt-to-Capital Ratio | 0.11 | 0.02 | 0.01 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.01 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.42 | 1.30 | 1.16 | 1.05 |
| Debt Service Coverage Ratio | -185.46 | -220.36 | -1661.34 | -3.42 |
| Interest Coverage Ratio | -419.27 | -1439.46 | -3225.82 | 0.00 |
| Debt to Market Cap | 0.02 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.10 | 0.70 | 0.12 | 4.72 |
| Profitability Margins | ||||
| Gross Profit Margin | 9.12% | 16.60% | 14.45% | -4219.81% |
| EBIT Margin | -704.27% | -818.64% | -8808.74% | -81474.53% |
| EBITDA Margin | -675.17% | -816.82% | -8769.58% | -80497.64% |
| Operating Profit Margin | -397.00% | -479.42% | -1043.84% | -81353.77% |
| Pretax Profit Margin | -705.22% | -818.97% | -8809.07% | -81473.11% |
| Net Profit Margin | -697.48% | -815.93% | -8809.07% | -81473.11% |
| Continuous Operations Profit Margin | -697.48% | -815.93% | -8771.75% | -81473.11% |
| Net Income Per EBT | 98.90% | 99.63% | 100.00% | 100.00% |
| EBT Per EBIT | 177.64% | 170.83% | 843.91% | 100.15% |
| Return on Assets (ROA) | -338.34% | -104.29% | -480.41% | -14.88% |
| Return on Equity (ROE) | -818.94% | -135.39% | -559.04% | -15.60% |
| Return on Capital Employed (ROCE) | -430.88% | -78.38% | -66.04% | -15.58% |
| Return on Invested Capital (ROIC) | -408.30% | -77.38% | -65.80% | -14.90% |
| Return on Tangible Assets | -435.72% | -122.99% | -776.04% | -14.88% |
| Earnings Yield | -230.13% | -115.40% | -63.31% | -0.74% |
| Efficiency Ratios | ||||
| Receivables Turnover | 4.61 | 1.83 | 8.89 | 0.00 |
| Payables Turnover | 1.57 | 1.88 | 0.44 | 0.48 |
| Inventory Turnover | 197.35 | 0.00 | 0.00 | 0.27 |
| Fixed Asset Turnover | 2.30 | 8.83 | 20.02 | 0.00 |
| Asset Turnover | 0.49 | 0.13 | 0.05 | 0.00 |
| Working Capital Turnover Ratio | 0.53 | 0.19 | 0.21 | 0.00 |
| Cash Conversion Cycle | -151.56 | 4.71 | -794.85 | 586.20 |
| Days of Sales Outstanding | 79.22 | 199.05 | 41.06 | 0.00 |
| Days of Inventory Outstanding | 1.85 | 0.00 | 0.00 | 1346.45 |
| Days of Payables Outstanding | 232.63 | 194.34 | 835.91 | 760.25 |
| Operating Cycle | 81.07 | 199.05 | 41.06 | 1346.45 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.03 | -0.03 | -0.03 | -0.01 |
| Free Cash Flow Per Share | -0.04 | -0.03 | -0.03 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -8.20 | -179.23 | -230.47 | -4.81 |
| Capital Expenditure Coverage Ratio | -8.20 | -179.23 | -230.47 | -4.81 |
| Operating Cash Flow Coverage Ratio | -35.72 | -20.82 | -47.01 | -5.78 |
| Operating Cash Flow to Sales Ratio | -3.93 | -3.04 | -5.01 | -1362.41 |
| Free Cash Flow Yield | -145.37% | -43.21% | -3.62% | -1.50% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -0.43 | -0.87 | -1.58 | -134.71 |
| Price-to-Sales (P/S) Ratio | 3.03 | 7.07 | 139.13 | 109755.77 |
| Price-to-Book (P/B) Ratio | 3.56 | 1.17 | 8.83 | 21.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.69 | -2.31 | -27.63 | -66.70 |
| Price-to-Operating Cash Flow Ratio | -0.77 | -2.33 | -27.75 | -80.56 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.01 | -0.00 | 0.00 |
| Enterprise Value Multiple | -0.35 | -0.17 | -1.46 | -131.63 |
| Enterprise Value | 4.46M | 2.05M | 129.31M | 22.46M |
| EV to EBITDA | -0.35 | -0.17 | -1.46 | -131.63 |
| EV to Sales | 2.36 | 1.38 | 128.23 | 105955.29 |
| EV to Free Cash Flow | -0.54 | -0.45 | -25.46 | -64.39 |
| EV to Operating Cash Flow | -0.60 | -0.45 | -25.57 | -77.77 |
| Tangible Book Value Per Share | 0.00 | 0.04 | 0.06 | 0.03 |
| Shareholders’ Equity Per Share | 0.01 | 0.05 | 0.10 | 0.03 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.01 | 0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.00 |
| Net Income Per Share | -0.06 | -0.07 | -0.56 | -0.00 |
| Tax Burden | 0.99 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.05 | 0.13 | 1.96 | 235.85 |
| SG&A to Revenue | 2.90 | 4.65 | 6.78 | 322.06 |
| Stock-Based Compensation to Revenue | 0.46 | 1.63 | 3.07 | 15178.65 |
| Income Quality | 0.56 | 0.37 | 0.06 | 1.67 |
Currency in CAD
